AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Inkmet M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Silhos Pharma Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Inkmet M 2mg/500mg Tablet SR

Diabetic patients using Metformin/Pioglitazone extended-release tablets (2mg/500mg) benefit from its dual-action approach to managing type 2 diabetes in adults. This medication effectively regulates blood glucose. Optimal results are achieved by taking this medication with food, consistently at the same time daily, as prescribed by your physician. Dosage adjustments may occur based on blood sugar monitoring. Consistent use is vital; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan incorporating a healthy diet, exercise, and weight management as directed by your doctor. Common side effects include hypoglycemia (low blood sugar), manifested by sweating, dizziness, headache, or tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended by your healthcare provider.

Primary Ingredients of Inkmet M 2mg/500mg Tablet SR

No text provided. Please provide the text you wish me to rephrase.

Uses of Inkmet M 2mg/500mg Tablet SR

Managing Type 2 diabetes

Major Benefits of Inkmet M 2mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. The Inkmet M 2mg/500mg Sustained-Release tablet should be taken with a meal.

Common Side effects of Inkmet M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Inkmet M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Inkmet M 2mg/500mg SR tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medication with food.

How Inkmet M 2mg/500mg Tablet SR works:

Inkmet M SR tablets (2mg/500mg) combine glimepiride and metformin, two agents that manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Inkmet M 2mg/500mg Tablet SR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Inkmet M 2mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Inkmet M tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Inkmet M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Inkmet M 2mg/500mg SR tablets. Physician consultation is advised. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Inkmet M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.

What if you forget to take Inkmet M 2mg/500mg Tablet SR :

Should you forget to take a scheduled Inkmet M 2mg/500mg Tablet SR, ingest it immediately upon remembering. Nevertheless, if your next dose is imminent, omit the missed dose and resume your typical dosing regimen. Avoid taking a double dose.

Facts to Know About Inkmet M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Inkmet M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container as directed on the label or packaging. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Inkmet M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is particularly risky for individuals with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Inkmet M 2mg/500mg Tablet SR and seek immediate medical attention.
Inkmet M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Inkmet M 2mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Inkmet M 2mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Inkmet M 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), characterized by symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Inkmet M 2mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Inkmet M 2mg/500mg Tablet...
53
MRP 65
18% off